Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathway

Sun, Hai-Jian; Zhao, Ming-Xia; Liu, Tong-Yan; Ren, Xing-Sheng; Chen, Qi; Li, Yue-Hua; Kang, Yu-Ming; Zhu, Guo-Qing

doi:10.1038/srep23596

Download PDF

Article
Open access
Published: 23 March 2016

Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathway

Hai-Jian Sun¹,
Ming-Xia Zhao¹,
Tong-Yan Liu¹,
Xing-Sheng Ren¹,
Qi Chen²,
Yue-Hua Li²,
Yu-Ming Kang³ &
…
Guo-Qing Zhu^1,2

Scientific Reports volume 6, Article number: 23596 (2016) Cite this article

2079 Accesses
39 Citations
1 Altmetric
Metrics details

Subjects

Abstract

Vascular smooth muscle cells (VSMCs) are indispensible components in foam cell formation. Salusin-β is a stimulator in the progression of atherosclerosis. Here, we showed that salusin-β increased foam cell formation evidenced by accumulation of lipid droplets and intracellular cholesterol content and promoted monocyte adhesion in human VSMCs. Salusin-β increased the expressions and activity of acyl coenzyme A:cholesterol acyltransferase-1 (ACAT-1) and vascular cell adhesion molecule-1 (VCAM-1) in VSMCs. Silencing of ACAT-1 abolished the salusin-β-induced lipid accumulation and silencing of VCAM-1 prevented the salusin-β-induced monocyte adhesion in VSMCs. Salusin-β caused p65-NFκB nuclear translocation and increased p65 occupancy at the ACAT-1 and VCAM-1 promoter. Inhibition of NFκB with Bay 11-7082 prevented the salusin-β-induced ACAT-1 and VCAM-1 upregulation, foam cell formation and monocyte adhesion in VSMCs. Scavenging ROS, inhibiting NADPH oxidase or knockdown of NOX2 abolished the effects of salusin-β on ACAT-1 and VCAM-1 expressions, p65-NFκB nuclear translocation, lipid accumulation and monocyte adhesion in VSMCs. Salusin-β increased miR155 expression and knockdown of miR155 prevented the effects of salusin-β on ACAT-1 and VCAM-1 expressions, p65-NFκB nuclear translocation, lipid accumulation, monocyte adhesion and ROS production in VSMCs. These results indicate that salusin-β induces foam formation and monocyte adhesion via miR155/NOX2/NFκB-mediated ACAT-1 and VCAM-1 expressions in VSMCs.

Smooth muscle liver kinase B1 inhibits foam cell formation and atherosclerosis via direct phosphorylation and activation of SIRT6

Article Open access 22 August 2023

Smooth muscle 22 alpha protein inhibits VSMC foam cell formation by supporting normal LXRα signaling, ameliorating atherosclerosis

Article Open access 22 October 2021

The miR-378c-Samd1 circuit promotes phenotypic modulation of vascular smooth muscle cells and foam cells formation in atherosclerosis lesions

Article Open access 18 May 2021

Introduction

Atherosclerosis is positively associated with the formation of foam cells characterized by cholesterol esters and triglycerides accumulation in the cytoplasm^1,2. The foam cell formation is a critical step in the atherosclerosis and plays essential role in the destabilization, rupture and erosion of atherosclerotic plaque³. Most of foam cells have been found to be derived from macrophages, but VSMCs give rise to a considerable number of foam cells as well⁴. Simultaneous thymidine autoradiography and immunostaining with cell type-specific monoclonal antibodies showed that about 30% of the labeled cells were macrophages and 45% were VSMCs in advanced atherosclerosis lesions in both Watanabe heritable hyperlipidemic rabbits and hypercholesterolemic fat-fed rabbits⁵. On the other hand, leukocyte recruitment from blood stream to the intima of vessels is a crucial event in the pathogenesis of atherosclerosis and a potential candidate for therapeutic approaches of atherosclerosis⁶. Cell adhesion molecules including intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are important for the initiating event of leukocyte recruitment to vascular endothelium and VSMCs in the development of atherosclerosis⁷. Although several adhesive mechanisms have been provided to be responsible for leukocyte recruitment in atherosclerosis, the mechanisms for the foam cell formation from VSMCs and the leukocyte recruitment in atherosclerosis are poorly elucidated.

Salusin-β is a peptide with 20 amino acids, which is translated from an alternatively spliced mRNA of TOR2A, a gene encoding a protein of the torsion dystonia family⁸. The initial 18 amino acids of human salusin-β have high homology with the N-terminal sequence of rat salusin⁹. Salusin-β is widely expressed within vasculature and central nervous system¹⁰. Our previous studies have showed that central salusin-β is involved in sympathetic activation and hypertension in hypertensive rats^11,12,13 and peripheral salusin-β contributes to vascular remodeling associated with hypertension by promoting human VSMC proliferation via cAMP-PKA-EGFR-CREB/ERK pathway and vascular fibrosis via TGF-β1-Smad pathway¹⁴. Salusin-β is dominantly detected within VSMCs and fibroblasts in the human coronary atherosclerotic plaques¹⁵. Atherosclerotic lesions are deteriorated in apolipoprotein E-deficient mice with chronic salusin-β infusion¹⁶. Plasma salusin-β levels in subjects with diabetes mellitus, coronary artery disease and cerebrovascular disease showed distinctly higher levels than healthy controls and it may contribute to the pathogenesis of atherosclerosis¹⁷. However, the roles of salusin-β in the foam formation and monocyte adhesion in human VSMCs are rarely known. Thus, fully elucidating the roles of salusin-β and its underlying mechanisms in the foam cell formation and monocyte adhesion in VSMCs may be useful for the prevention and treatment of vascular lesions in atherosclerosis.

Results

Effects of salusin-β on foam cell formation and monocyte recruitment

Salusin-β dose- and time-relatedly increased the accumulation of lipid droplets in VSMCs and the adhesion of monocyte to VSMCs and the maximal effects were observed at the dose of 30 nM of salusin-β for 48 h (Fig. 1A,B). Total intracellular cholesterol quantification and the number of adherent cells further confirmed that salusin-β stimulated VSMC foam cell formation and monocyte recruitment (Fig. 1C,D).

Effects of salusin-β on ACAT-1 and VCAM-1

It is known that ACAT-1 promotes foam cell formation by promoting intracellular cholesteryl ester synthesis¹⁸ and VCAM-1 are an important cell adhesion molecule for leukocyte recruitment in the development of atherosclerosis⁷. Salusin-β upregulated the ACAT-1 and VCAM-1 protein levels in VSMCs in concentration- and time-dependent manner and the maximal effects were found at the concentration of 30 nM of salusin-β for 48 h (Fig. 2A,B). Furthermore, it increased ACAT-1 and VCAM-1 mRNA levels, which were parallel to those of protein expressions (Fig. 2C). Luciferase reporter genes assay showed that salusin-β enhanced the promoter activities in the ACAT-1 and VCAM-1 truncated forms containing proximal NF-κB binding sites (Fig. 2D).

ACAT-1 or VCAM-1 siRNA retards effects of salusin-β

To determine the importance of ACAT-1 in salusin-β-induced foam cell formation or VCAM-1 in salusin-β-induced monocyte recruitment, the effects of ACAT-1 siRNA and VCAM-1 siRNA were examined. Knockdown of ACAT-1 impeded salusin-β-induced accumulation of lipid droplets and increase in total intracellular cholesterol contents in VSMCs (Fig. 3A,C), but had no significant effects on salusin-β-induced monocyte adhesion in VSMCs (Fig. S1). Knockdown of VCAM-1 prevented salusin-β-induced monocyte adhesion in VSMCs (Fig. 3B,D), but had no significant effects on salusin-β-induced accumulation of lipid droplets and increase in total intracellular cholesterol contents in VSMCs (Fig. S2). The knockdown efficiency was confirmed by the reduced protein expression in VSMCs (Fig. S3). Moreover, ACAT-1 overexpression promoted foam formation in VSMCs (Fig. S4) and VCAM-1 overexpression increased the adhesion of monocyte to VSMCs in VSMCs (Fig. S5). The efficiency of overexpression was confirmed by the increased protein expressions in VSMCs (Fig. S6).

NF-κB activation contributes to effects of salusin-β

Salusin-β elicited an increase in nuclear p65-NFκB levels and a reduction in cytoplasmic p65-NFB levels in VSMCs in dose-related manner (Fig. 4A) and time-related manner (Fig. S7). As expected, salusin-β increased the binding of NF-κB to ACAT-1 and VCAM-1 promoter in VSMCs (Fig. 4B). Inhibition of NFκB with Bay11-7082 repressed the NFκB activity and nuclear NFκB level response to salusin-β in VSMCs (Fig. S8). The up-regulated ACAT-1 and VCAM-1 expressions in response to salusin-β were abrogated by inhibition of NFκB with Bay11-7082 (Fig. 4C). Pretreatment with Bay11-7082 inhibited the salusin-β-induced foam cell formation and adhesion of monocyte to VSMCs (Fig. 4D,E).

NOX2-derived ROS mediates the effects of salusin-β

Incubation of VSMCs with salusin-β dose- and time- relatedly increased NADPH oxidase 2 (NOX2) expressions (Fig. 5A) and ROS production (Fig. 6A). Salusin-β-induced ACAT-1 and VCAM-1 expressions and p65-NFκB nuclear translocation in VSMCs were prevented by the treatment with a ROS scavenger N-acetyl-cysteine (NAC), a NADPH oxidase inhibitor apocynin or knockdown of NOX2 with siRNA (Fig. 5B–D). Importantly, incubation of VSMCs with NAC, apocynin or NOX2 siRNA abolished the salusin-β-induced foam cell formation and adhesion of monocyte to VSMCs (Fig. 6B–G). Furthermore, salusin-β increased the ROS production, which were attenuated by NAC, apocynin or NOX2 siRNA (Fig. S9).

miR155 is responsible for effects of salusin-β

Salusin-β time-relatedly increased miR155 expression in VSMCs and the maximal effect was observed at 48 hours after salusin-β treatment (Fig. 7A). Treatment with miR155 inhibitor in VSMCs prevented salusin-β-induced foam cell formation, monocyte adhesion to VSMCs, ROS production (Fig. 7B,D) and NOX2 expression (Fig. 7C,G). Furthermore, salusin-β-induced ACAT-1 and VCAM-1 expressions and p65-NFκB nuclear translocation were diminished by miR155 inhibitor transfection in VSMCs (Fig. 7E–G). The efficiency of miR155 inhibitor was confirmed by the downregulation of miR155 levels in VSMCs (Fig. S10).

Discussion

Atherosclerosis is a crucial underlying pathology of cardiovascular diseases. Foam cell formation is a major hallmark of early stage atherosclerotic lesions¹⁹. ACAT-1 is a key enzyme for intracellular cholesteryl ester synthesis¹⁸. Excessive cholesterol esterification resulted in accumulation of cholesterol ester stored as cytoplasmic lipid droplets and subsequently trigger the formation of foam cells¹⁹. Foam cells are not only derived from macrophages, but also from VSMCs⁴. It is known that circulating salusin-β levels is increased in coronary artery disease²⁰ and salusin-β increased ACAT-1 expression in human monocyte-derived macrophages¹⁵. We found that salusin-β increased the accumulation of lipid droplets and intracellular total cholesterol content indicating that salusin-β promoted VSMCs-derived foam cell formation. In support of this notion, we found that ACAT-1 mRNA and protein expressions as well as the promoter activity in the ACAT-1 were upregulated in salusin-β-treated VSMCs and knockdown of ACAT-1 with siRNA diminished salusin-β-induced increases in lipid droplets and intracellular total cholesterol contents in VSMCs. The results indicate the importance of ACAT-1 in salusin-β-induced foam cell formation from VSMCs.

Recruitments of monocytes and monocyte-derived phagocytes into the wall of large arteries accelerate the chronic inflammation and atherosclerosis²¹. ICAM-1 and VCAM-1 are important cell adhesion molecules and are merged as functional mediators in monocyte extravasation²². VCAM-1 expression is found in VSMCs, which promotes the migration of monocytes and lymphocytes into the vessel wall²³. We found that salusin-β promoted the monocyte adhesion to VSMCs and increased VCAM-1 mRNA and protein expressions as well as the promoter activity in the VCAM-1 in VSMCs. Knockdown of VCAM-1 with siRNA prevented the salusin-β-induced monocyte adhesion. These results indicate that salusin-β promotes monocyte recruitment to VSMCs and VCAM-1 is pivotal for the monocyte recruitment in VSMCs.

Transcription factor NFκB is implicated in inflammatory activation associated with the onset of atherosclerosis²⁴. Translocation of p65 of NFκB from cytoplasm to nucleus is recognized as a prerequisite for the transcription²⁵. VCAM-1 and ACAT-1 expressions at sites of atherosclerotic lesion formation are majorly controlled by NFκB system in early atherosclerotic lesions²⁶. We found that salusin-β induced p65-NFκB nuclear translocation and recruitment of p65 to promoters of ACAT-1 and VCAM-1 in VSMCs. Inhibition of NFκB suppressed the salusin-β-induced ACAT-1 and VCAM-1 expressions, lipid accumulation in VSMCs and monocyte adhesion to VSMCs. These results indicate that p65-NFκB nucleus translocation is necessary for salusin-β-induced ACAT-1 and VCAM-1 expressions and the following foam cell formation from VSMCs and monocyte recruitment to VSMCs.

ROS is a critical contributor in the initiation and progression of atherosclerosis²⁷. NFκB is a redox-sensitive transcription factor and can be regulated by intracellular redox status²⁸. A major source for ROS in cardiovascular system is a family of NOX^29,30. Our recent studies have shown that NAD(P)H oxidase-derived ROS in the brain is responsible for salusin-β-induced sympathetic activation^12,13. In the present study, we found that salusin-β increased NOX2 expression and ROS production in VSMCs. Scavenging ROS, inhibiting NADPH oxidase or downregulating NOX2 abolished salusin-β-induced p65-NFκB nuclear translocation, ACAT-1 and VCAM-1 expressions, foam cell formation and monocyte adhesion in VSMCs. These results indicate that NOX2-derived ROS is a major downstream mediator of salusin-β in the ROS production and the subsequent p65-NFκB nuclear translocation, ACAT-1 and VCAM-1 expressions, foam cell formation and monocyte adhesion in VSMCs. MicroRNAs are small RNA molecules that regulate gene expression at post-transcriptional level³¹. MicroRNA-155 (miR155) is dominantly expressed in the atherosclerotic plaques and proinflammatory macrophages and loss of miR155 reduces the proinflammatory NF-κB signaling associated with decreased recruitment of monocytes to atherosclerotic plaques³². Deficiency of miR155 attenuates atherogenesis in apolipoprotein E-deficient mice³³. We found that salusin-β up-regulated miR155 level in VSMCs. Knockdown of miR155 abolished the salusin-β-induced NOX2 upregulation, ROS production, p65-NFκB nuclear translocation, ACAT-1 and VCAM-1 expressions, foam cell formation and monocyte adhesion in VSMCs. These results indicate that miR155 is crucial in salusin-β-induced oxidative stress and subsequent cascade process. A limitation in the present study was that the results were not examined in vivo, which need further investigation.

In conclusion, salusin-β upregulates miR155 in VSMCs, which increases NOX2-derived ROS production and subsequent nucleus translocation of p65-NFκB. The activation of NFκB promotes ACAT-1 and VCAM-1 expressions and then causes foam cell formation from VSMCs and monocyte adhesion to VSMCs. Intervention of salusin-β may be a promising strategy for retarding the vascular lesions in atherosclerosis.

Methods

Cell culture

Human aortic VSMCs were obtained from American Type Culture Collection (Rockville, MD, USA). VSMCs were cultured as we previously reported¹⁴. In brief, VSMCs were maintained F12K Kaighn’s modification medium containing 10% fetal bovine serum (FBS) supplemented with 1× penicillin and streptomycin in a humidified cell incubator with standard cell culture condition (37 °C at 5% CO₂ humidified atmosphere). Cells between passages 3 and 8 were used for the experiments. When cells reached 70–80% confluence, the cells were starved for 24 h in serum-free medium prior to use³⁴.

Oil red O staining

Oil red O staining for VSMCs was conducted according to previous study³⁵. Simply, cultured VSMCs were plated on the 24-well plates and reached to 70–80% confluence and then incubated with or without different doses of salusin-β for 12, 24 or 48 h in serum-free media. Afterwards, VSMCs were washed with 0.01 M PBS for three times and stained with Oil Red O and Harris’ hematoxylin. The images were captured under a microscope at ×400 magnification.

Intracellular total cholesterol measurement

Intracellular total cholesterol level was determined by enzymatic assay (Applygen Technologies, Beijing, China). Briefly, VSMCs were harvested into a centrifuge tube and then washed with PBS three times. Isopropylalcohol was employed to extract the intracellular lipids by ultrasonication. After centrifugation for 5 min at 2,000 g, the supernatant was used to determine the total cholesterol. The total cellular protein levels were quantified by Bradford assay method. The results in each sample were expressed in nmol of cholesterol per milligram of cellular protein and finally normalized to those of the control³⁶.

In vitro monocyte adhesion assay

Monocyte-VSMC binding assays were carried out as described previously³⁷. U937 cells (monocytes) were purchased from FuDan IBS Cell Center (Shanghai, China) and cultured in RPMI-1640 Medium supplemented with 10% FBS. The VSMCs were incubated with or without salusin-β for 12, 24 or 48 h, respectively and followed by two rinses with PBS. Then, U937 cells (1 × 10⁶ cells/well) were added to VSMC culture and incubated for 1 h at 10 rpm at 37 °C. The medium was then drained and washed twice with FBS for removing the non-attached cells, the VSMC layers with attached monocytes were fixed with 4% paraformaldehyde and measured with a microscope at ×200 filed. The number of attached monocyte was randomly counted in five areas per well from three independent experiments and averaged.

siRNA transfection

Human acyl coenzyme A:cholesterol acyltransferase-1 (ACAT-1) siRNA or human VCAM-1 siRNA (Santa Cruz, CA, USA) was transfected to human VSMCs as previously described^38,39. Recommended scrambled siRNA (Santa Cruz, CA, USA) was used as a negative control. The human VSMCs were transfected with 100 nM of indicated siRNA with Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) for 24 h, the cells were plated for foam formation and monocyte adhesion assay after the 48 h of salusin-β treatment.

Reporter gene transfection and luciferase activity assay

The forms of human VCAM-1 luciferase plasmids spanning −1350 to +45 bp or the core regions (−125 to +34) of human ACAT-1 proximal promoter was cloned into pGL3 basic luciferase reporter vector (Promega, WI, USA) as previous report^18,40. VSMCs were transfected with 1 μg of luciferase plasmids or control pCMV-β-gal plasmid with lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) for 24 h. VSMCs were harvested and luciferase activity was measured using a dual luciferase reported gene assay kit (Beyotime Biotechnology, Shanghai, China). The luciferase activity was normalized to the internal control.

Western Blot

VSMCs were lysed in lysis buffer and incubated for 30 min on the ice, the supernatant was retained after centrifugation. The total protein concentration in the supernatant was quantified with the Bradford assay (Santa Cruz, CA, USA). Equal amounts of protein in each sample were separated by SDS-PAGE electrophoresis and transferred to PVDF membrane. The membrane was blocked with 5% milk blocking buffer and incubated with the designed primary antibodies overnight at 4 °C. Horseradish peroxidase-conjugated secondary antibodies were used for detection. The protein bands were visualized with Enhanced Chemiluminescence Detection Kit (Thermo Scientific, Rockford, IL, USA).

Real-time PCR

Total RNA was extracted with Trizol reagent following the manufacturer’s instructions. The cDNAs of human ACAT-1 and VCAM-1 were reversed with the PrimeScript^® RT reagent Kit and subjected to PCR amplification with SYBR Premix Ex Taq TM (Takara, Otsu, Shiga, Japan) on a StepOnePlus system (Applied Biosystems, Foster City, CA, USA). GAPDH was served as an internal control for mRNAs. Measurement of miR155 was conducted as previously reported^41,42. Simply, the miR155 cDNAs were synthesized with Hairpin-it^TM miRNAs RT-PCR Quantitation kit (GenePharma, Shanghai, China) following the manufacturer’s protocols and then real-time PCR was performed to determine the miR155 levels. U6 was served as an internal control for miR155. QPCR data was analyzed with cycle thresholds (Ct) methods and relative abundance of mRNA was normalized to the value of the house-keeping gene. The sequence-specific primers used were as follows. Human ACAT-1: 5′-TTCGGAATATCAAACAGGAGCC-3′ (forward), 5′-CACACCTGGCAAGATGGAGTT-3′ (reverse); human VCAM-1: 5′-CCTGCCATTGGAATGATAA-3′ (forward), 5′-TGCTTCTACAAGACTATATGAC-3′ (reverse); human GAPDH: 5′-TGTTGCCATCAATGACCCCTT-3′ (forward), 5′-CTCCACGACGTACTCAGCG-3′ (reverse). miR155: 5-GCTTCGGTTAATGCTAATCGTG-3 (forward), 5-CAGAGCAGGGTCCGAGGTA-3 (reverse); U6: 5-CTCGCTTCGGCAGCACA-3 (sense), 5-AACGCTTCACGAAYY YGCGT-3 (reverse)¹⁵.

Preparation of cytoplasmic fractions and nuclear extracts

Nuclear and cytoplasmic extracts were prepared and obtained as previous report⁴³. The purity of nuclear extracts was evaluated by immunoblotting with incubation of primary antibodies against lamin B1 (Santa Cruz, CA, USA). The purity of cytoplasmic fractions was confirmed by immunoblotting with primary antibodies against GAPDH (Santa Cruz Biotechnology, CA, USA).

Chromatin immunoprecipitation (ChIP)

ChIP assays were conducted as described previously⁴⁴. The ChIP-enriched DNA fragments were immunoprecipitated in the presence or absence of p65 and Pol II antibodies and a rabbit monoclonal control IgG (Santa Cruz Biotechnology, CA, USA). qPCR was used to assess the NFκB and Pol II binding site on the ACAT-1 and VCAM-1 promoters. The data were quantified and normalized with input samples and expressed as fold change of control. Precipitated DNA fragments were amplified by PCR. The primers encompassing the p65 site were as follows. In ACAT-1 promoter: 5′-CTTAACCTGGGGACCACCAATAG-3′ (forward), 5′-CTTCTATTGGTGGTCCCCAGGTT-3 (reverse)⁴⁰; in VCAM-1 promoter: 5′-AAATCAATTCACATGGCATA-3′ (forward), 5′-AAGGGTCTTGTTGCAGAGG-3′ (reverse)⁴⁵.

Lentiviral vector transduction in VSMCs

VSMCs were seeded at 10⁵cells/well in 6-well plates 24 h prior to transfection. The VSMCs were grown to a 40–60% confluence and transfected with recombinant lentivirus vector harboring ACAT-1 (sc-402300-LAC, Santa Cruz, CA, USA) or VCAM-1 (sc-400135-LAC, Santa Cruz, CA, USA) in serum-free growth medium overnight. The viruses contained medium was replaced with 3 ml of standard medium. Measurements were conducted 2 days after transfection⁴⁶.

Measurement of ROS generation

DHE fluorescent dye was used to determine intracellular superoxide anion generation in VSMCs as previous report⁴⁷. VSMCs were fixed and loaded with DHE (10 μmol/L) for 30 min in a light-protected humidified chamber. The fluorescence (488/525 nm) were obtained with fluorescence microscope.

Chemicals and antibodies

Human salusin-β was obtained from Phoenix Pharmaceuticals (Belmont, CA, USA). Cell culture supplies were purchased from Costar (Corning Inc., Cypress, CA, USA). Antibodies against ACAT-1, VCAM-1, GAPDH, Lamin B1 and indicated horseradish peroxidase (HRP) conjugated secondary antibodies were purchased from Santa Cruz Biotechnology Co. (Santa Cruz, CA, USA). Antibody against p65 was obtained from Cell Signaling Technology (Beverly, MA, USA). Antibody against NOX2 was purchased from Abcam (Cambridge, MA, USA). Sequence of human miR155 inhibitor is 5′-ACCCCUAUCACAAUUAGCAUUAA-3′ and the sequence of its control is 5′-CAGUACUUUUGUGUAGUACAA-3′ (GenePharma, Shanghai, China). Bay11-7082, N-acetyl-L-cysteine (NAC), deihydroethidium and the reporter plasmid pGL6-NFκB-Luc for measurement of NFκB activity were obtained from Beyotime Biotechnology (Shanghai, China). Apocynin and dimethyl sulfoxide (DMSO) were obtained from Sigma Chemical (St. Louis, MO, USA).

Statistical analysis

Data were expressed as mean ± S.E.M. One-way or two-way ANOVA followed by post hoc Bonferroni test was used for multiple comparisons. A value of P < 0.05 was considered statistically significant.

Additional Information

How to cite this article: Sun, H.-J. et al. Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathway. Sci. Rep. 6, 23596; doi: 10.1038/srep23596 (2016).

References

Ullery-Ricewick, J. C., Cox, B. E., Griffin, E. E. & Jerome, W. G. Triglyceride alters lysosomal cholesterol ester metabolism in cholesteryl ester-laden macrophage foam cells. J Lipid Res 50, 2014–2026 (2009).
CAS PubMed PubMed Central Google Scholar
Khan, S. et al. Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci Rep 4, 4680 (2014).
PubMed PubMed Central Google Scholar
Angelovich, T. A., Hearps, A. C. & Jaworowski, A. Inflammation-induced foam cell formation in chronic inflammatory disease. Immunol Cell Biol 93, 683–693 (2015).
CAS PubMed Google Scholar
Chaabane, C., Coen, M. & Bochaton-Piallat, M. L. Smooth muscle cell phenotypic switch: implications for foam cell formation. Curr Opin Lipidol 25, 374–379 (2014).
CAS PubMed Google Scholar
Rosenfeld, M. E. & Ross, R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 10, 680–687 (1990).
CAS PubMed Google Scholar
Braunersreuther, V. & Mach, F. Leukocyte recruitment in atherosclerosis: potential targets for therapeutic approaches? Cell Mol Life Sci 63, 2079–2088 (2006).
CAS PubMed Google Scholar
Ling, S., Nheu, L. & Komesaroff, P. A. Cell adhesion molecules as pharmaceutical target in atherosclerosis. Mini Rev Med Chem 12, 175–183 (2012).
CAS PubMed Google Scholar
Shichiri, M. et al. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med 9, 1166–1172 (2003).
CAS PubMed Google Scholar
Suzuki, N. et al. Systemic distribution of salusin expression in the rat. Hypertens Res 30, 1255–1262 (2007).
CAS PubMed Google Scholar
Li, H. B. et al. Central blockade of salusin beta attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats. Sci Rep 5, 11162 (2015).
ADS CAS PubMed PubMed Central Google Scholar
Chen, W. W. et al. Salusin-beta in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats. Cardiovasc Res 98, 344–351 (2013).
CAS PubMed Google Scholar
Sun, H. J. et al. Superoxide anions involved in sympathoexcitation and pressor effects of salusin-beta in paraventricular nucleus in hypertensive rats. Acta Physiol (Oxf) 210, 534–545 (2014).
ADS CAS Google Scholar
Zhang, L. L. et al. Salusin-beta in rostral ventrolateral medulla increases sympathetic outflow and blood pressure via superoxide anions in hypertensive rats. J Hypertens 32, 1059–1067 (2014).
CAS PubMed Google Scholar
Sun, H. J. et al. Salusin-beta contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis. Biochim Biophys Acta 1852, 1709–1718 (2015).
CAS PubMed Google Scholar
Watanabe, T. et al. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation 117, 638–648 (2008).
CAS PubMed Google Scholar
Nagashima, M. et al. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 212, 70–77 (2010).
CAS PubMed Google Scholar
Fujimoto, K. et al. Circulating levels of human salusin-beta, a potent hemodynamic and atherogenesis regulator. Plos One 8, e76714 (2013).
ADS CAS PubMed PubMed Central Google Scholar
Min, J. K. et al. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ Res 96, 300–307 (2005).
CAS PubMed Google Scholar
Yu, X. H., Fu, Y. C., Zhang, D. W., Yin, K. & Tang, C. K. Foam cells in atherosclerosis. Clin Chim Acta 424, 245–252 (2013).
CAS PubMed Google Scholar
Sato, K., Watanabe, R., Itoh, F., Shichiri, M. & Watanabe, T. Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases. Int J Hypertens 2013, 965140 (2013).
PubMed PubMed Central Google Scholar
Gerhardt, T. & Ley, K. Monocyte trafficking across the vessel wall. Cardiovasc Res 107, 321–330 (2015).
CAS PubMed PubMed Central Google Scholar
Hsu, W. Y. et al. Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway. J Cell Physiol 226, 2181–2188 (2011).
CAS PubMed Google Scholar
Doran, A. C., Meller, N. & McNamara, C. A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28, 812–819 (2008).
CAS PubMed PubMed Central Google Scholar
Wang, L., Qiu, X. M., Hao, Q. & Li, D. J. Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor beta mediating nitric oxide production and NF-kappaB suppression in endothelial cells. Cell Death Dis 4, e551 (2013).
CAS PubMed PubMed Central Google Scholar
Yan, S. et al. Clematichinenoside inhibits VCAM-1 and ICAM-1 expression in TNF-alpha-treated endothelial cells via NADPH oxidase-dependent IkappaB kinase/NF-kappaB pathway. Free Radic Biol Med 78, 190–201 (2015).
CAS PubMed Google Scholar
Sato, J. et al. Family with sequence similarity 5, member C (FAM5C) increases leukocyte adhesion molecules in vascular endothelial cells: implication in vascular inflammation. Plos One 9, e107236 (2014).
ADS PubMed PubMed Central Google Scholar
Zampetaki, A., Dudek, K. & Mayr, M. Oxidative stress in atherosclerosis: the role of microRNAs in arterial remodeling. Free Radic Biol Med 64, 69–77 (2013).
CAS PubMed Google Scholar
Chen, G. F. et al. Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function. Sci Rep 5, 14780 (2015).
ADS CAS PubMed PubMed Central Google Scholar
Brandes, R. P. Vascular functions of NADPH oxidases. Hypertension 56, 17–21 (2010).
CAS PubMed Google Scholar
Sun, J. et al. Apocynin suppression of NADPH oxidase reverses the aging process in mesenchymal stem cells to promote osteogenesis and increase bone mass. Sci Rep 5, 18572 (2015).
ADS CAS PubMed PubMed Central Google Scholar
Schober, A., Nazari-Jahantigh, M. & Weber, C. MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis. Nat Rev Cardiol 12, 361–374 (2015).
CAS PubMed Google Scholar
Nazari-Jahantigh, M. et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 122, 4190–4202 (2012).
CAS PubMed PubMed Central Google Scholar
Du, F. et al. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 34, 759–767 (2014).
CAS PubMed PubMed Central Google Scholar
Yamamoto, K., Ohishi, M., Ho, C., Kurtz, T. W. & Rakugi, H. Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activation. Hypertension 54, 1353–1359 (2009).
CAS PubMed Google Scholar
Yin, Y. W. et al. TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression. Cell Death Dis 5, e1574 (2014).
CAS PubMed PubMed Central Google Scholar
Jiagang, D. et al. Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells. Biochem Biophys Res Commun 411, 523–529 (2011).
PubMed Google Scholar
Usui, T., Okada, M., Hara, Y. & Yamawaki, H. Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats. Hypertension 60, 1031–1039 (2012).
CAS PubMed Google Scholar
Huttunen, H. J., Greco, C. & Kovacs, D. M. Knockdown of ACAT-1 reduces amyloidogenic processing of APP. FEBS Lett 581, 1688–1692 (2007).
CAS PubMed PubMed Central Google Scholar
Wang, P. C. et al. Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells. Int J Mol Sci 15, 3560–3579 (2014).
CAS PubMed PubMed Central Google Scholar
Lei, L. et al. TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation. J Lipid Res 50, 1057–1067 (2009).
ADS CAS PubMed PubMed Central Google Scholar
Liu, L., Hu, Y., Fu, J., Yang, X. & Zhang, Z. MicroRNA155 in the growth and invasion of salivary adenoid cystic carcinoma. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 42, 140–147 (2013).
CAS Google Scholar
Liu, Y. et al. MicroRNA-155 Regulates ROS Production, NO Generation, Apoptosis and Multiple Functions of Human Brain Microvessel Endothelial Cells Under Physiological and Pathological Conditions. Journal of cellular biochemistry 116, 2870–2881 (2015).
CAS PubMed Google Scholar
Liang, C. J. et al. Viscolin reduces VCAM-1 expression in TNF-alpha-treated endothelial cells via the JNK/NF-kappaB and ROS pathway. Free Radic Biol Med 51, 1337–1346 (2011).
CAS PubMed Google Scholar
Zhong, Q. & Kowluru, R. A. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 62, 2559–2568 (2013).
CAS PubMed PubMed Central Google Scholar
Hwang, H. J. et al. Progranulin protects vascular endothelium against atherosclerotic inflammatory reaction via Akt/eNOS and nuclear factor-kappaB pathways. Plos One 8, e76679 (2013).
ADS CAS PubMed PubMed Central Google Scholar
Lv, L. et al. Lentivirus-mediated RNA interference targeting STAT4 inhibits the proliferation of vascular smooth muscle cells. Archives of medical research 39, 582–589 (2008).
CAS PubMed Google Scholar
Bruder-Nascimento, T. et al. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. J Mol Cell Cardiol 66, 18–26 (2014).
CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

This work was supported by National Natural Science Foundation of China (31171095, 31271213, 91439120 & 31571167). The authors gratefully acknowledge the generous support of the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine.

Author information

Authors and Affiliations

Department of Physiology, Key Laboratory of Cardiovascular Disease and Molecular Intervention, Nanjing Medical University, Nanjing, 210029, Jiangsu, China
Hai-Jian Sun, Ming-Xia Zhao, Tong-Yan Liu, Xing-Sheng Ren & Guo-Qing Zhu
Department of Pathophysiology, Nanjing Medical University, Nanjing, 210029, Jiangsu, China
Qi Chen, Yue-Hua Li & Guo-Qing Zhu
Department of Physiology and Pathophysiology, Cardiovascular Research Center, Xi’an Jiaotong University School of Medicine, 710061, Xi’an, China
Yu-Ming Kang

Authors

Hai-Jian Sun
View author publications
You can also search for this author in PubMed Google Scholar
Ming-Xia Zhao
View author publications
You can also search for this author in PubMed Google Scholar
Tong-Yan Liu
View author publications
You can also search for this author in PubMed Google Scholar
Xing-Sheng Ren
View author publications
You can also search for this author in PubMed Google Scholar
Qi Chen
View author publications
You can also search for this author in PubMed Google Scholar
Yue-Hua Li
View author publications
You can also search for this author in PubMed Google Scholar
Yu-Ming Kang
View author publications
You can also search for this author in PubMed Google Scholar
Guo-Qing Zhu
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the work in this paper. H.J.S. and G.Q.Z. designed the experiments. H.J.S., M.X.Z., T.Y.L. and X.S.R. performed experiments. H.J.S. and G.Q.Z. analyzed the data. G.Q.Z. wrote the draft of the manuscript. Q.C., Y.H.L. and Y.M.K. provided intellectual input and critically reviewed the manuscript.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Electronic supplementary material

Supplementary Information

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Reprints and permissions

About this article

Cite this article

Sun, HJ., Zhao, MX., Liu, TY. et al. Salusin-β induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFκB pathway. Sci Rep 6, 23596 (2016). https://doi.org/10.1038/srep23596

Download citation

Received: 14 January 2016
Accepted: 09 March 2016
Published: 23 March 2016
DOI: https://doi.org/10.1038/srep23596

This article is cited by

PRMT5 critically mediates TMAO-induced inflammatory response in vascular smooth muscle cells
- He Liu
- Kunpeng Jia
- Li-Long Pan
Cell Death & Disease (2022)
A TOR2A Gene Product: Salusin-β Contributes to Attenuated Vasodilatation of Spontaneously Hypertensive Rats
- Shuo Sun
- Feng Zhang
- Ying Han
Cardiovascular Drugs and Therapy (2021)
Lipocalin-2 exerts pro-atherosclerotic effects as evidenced by in vitro and in vivo experiments
- Koichiro Shibata
- Kengo Sato
- Takuya Watanabe
Heart and Vessels (2020)
NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension
- Hai-Jian Sun
- Xing-Sheng Ren
- Guo-Qing Zhu
Cell Death & Disease (2017)
Silencing salusin-β attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats
- Xing-Sheng Ren
- Li Ling
- Guo-Qing Zhu
Scientific Reports (2017)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.